NIDHI MORE: Open Payments
NPI 1891460507 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,245 in 47 payments from 18 companies in 2025. Trend: 2023 $271 · 2024 $1,183 · 2025 $1,245
Food & beverage: $1,245
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 9 | $358 |
| Amgen Inc. | 6 | $206 |
| Otsuka America Pharmaceutical, Inc. | 4 | $84 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| Ardelyx, Inc. | 4 | $71 |
| Calliditas Therapeutics US Inc. | 3 | $67 |
| Fresenius USA Marketing, Inc. | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| SCPHARMACEUTICALS INC. | 1 | $38 |
Products named: TAVNEOS, Filspari, JYNARQUE, FARXIGA, IBSRELA, TARPEYO, VELPHORO, Fabhalta.
Industry payments across KY — which companies pay providers there.
